Author:
Manning Mark Cornell,Holcomb Ryan E.,Payne Robert W.,Stillahn Joshua M.,Connolly Brian D.,Katayama Derrick S.,Liu Hongcheng,Matsuura James E.,Murphy Brian M.,Henry Charles S.,Crommelin Daan J. A.
Publisher
Springer Science and Business Media LLC
Reference1174 articles.
1. Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27:544–75.
2. Manning MC, Patel K, Borchardt RT. Stability of protein pharmaceuticals. Pharm Res. 1989;6:903–18.
3. Walsh G, Walsh E. Biopharmaceutical benchmarks 2022. Nat Biotechnol. 2022;40:1722–60.
4. Alt N, Zhang TY, Motchnik P, Taticek R, Quarmby V, Schlothauer T, Beck H, Emrich T, Harris RJ. Determination of critical quality attributes for monoclonal antibodies using quality by design principles. Biologicals. 2016;44:291–305.
5. Chan CP. Critical quality attributes assessment and testing strategy for biotherapeutics development. Am Pharm Rev. 2019;22:29–33.